Targeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity.
Bourquin C, Anz D, Zwiorek K, Lanz AL, Fuchs S, Weigel S, Wurzenberger C, von der Borch P, Golic M, Moder S, Winter G, Coester C, Endres S.
Bourquin C, et al. Among authors: winter g.
J Immunol. 2008 Sep 1;181(5):2990-8. doi: 10.4049/jimmunol.181.5.2990.
J Immunol. 2008.
PMID: 18713969